Posted by Michael Wonder on 11 Dec 2024
FDA approves Acetadote sNDA
9 December 2024 - New dosing regimen simplifies administration.
Cumberland Pharmaceuticals announced today the FDA has approved a supplemental new drug application for its Acetadote (N-acetylcysteine for injection) product.
